Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: Steri-Oss

This article was originally published in The Gray Sheet

Executive Summary

Steri-Oss: Dental implant system manufacturer plans to go public via an initial offering of 4.7 mil. shares at $14-16 per share, according to an initial prospectus filed with the Securities and Exchange Commission. About 10.9 mil. shares would be outstanding after the offering. Anticipated net proceeds of about $64.9 mil. (assuming an IPO price of $15) are tabbed for debt repayment, redemption of Class A, B and C preferred stock, working capital and general corporate purposes. Much of the debt stemmed from the November 1996 leveraged buyout of the business from Bausch & Lomb. Steri-Oss' majority shareholder, The 1818 Fund II, L.P., will reduce its stake to 38% from 66.6% after the offering.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008754

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel